Returning Alzheimer Disease biomarker results to older adults
Returning AD biomarker Results to Community Dwelling Older Adults: Testing Modalities and Impact
This study is looking at a new blood test that can help find early signs of Alzheimer’s disease before symptoms show, and it aims to find the best way to share these results with older adults so they can better understand their health and make informed choices.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10980340 on NIH RePORTER |
What this research studies
This research aims to develop a method for safely and clearly communicating Alzheimer Disease (AD) biomarker results to older adults. It focuses on the use of a new blood-based biomarker test that can identify preclinical AD, which occurs before symptoms appear. The study will evaluate how these results can be shared directly with participants, enhancing their understanding and involvement in their health decisions. This approach is particularly relevant now that new treatments targeting AD brain pathology have been approved, making early detection potentially actionable.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and above who are interested in understanding their risk for Alzheimer Disease.
Not a fit: Patients who are under 65 years old or those who do not have an interest in Alzheimer Disease biomarker testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could empower older adults with critical information about their Alzheimer Disease risk, enabling earlier intervention and treatment.
How similar studies have performed: Other research has shown promise in using blood-based biomarkers for early detection of Alzheimer Disease, indicating that this approach is gaining traction in the field.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Mozersky, Jessica — Washington University
- Study coordinator: Mozersky, Jessica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.